TickerFacts.

Interpace Biosciences, Inc. (IDXG): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2017-03-31; 1-for-10, first reflected in a filing dated 2020-04-22. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

27.70M
Year ended 2025-12-31
+87.0%
3-year compound annual growth
+47.0%
5-year compound annual growth
2010-12-31: 14.31M2011-12-31: 14.44M2012-12-31: 14.59M2013-12-31: 14.72M2014-12-31: 14.90M2015-12-31: 1.55M2016-12-31: 1.82M2017-12-31: 15.77M2018-12-31: 2.82M2019-12-31: 3.75M2020-12-31: 4.03M2021-12-31: 4.13M2022-12-31: 4.24M2023-12-31: 4.36M2024-12-31: 15.73M2025-12-31: 27.70M27.70M
2010-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3127.70M+76.0%2026-03-30, From 2025-01-01
2024-12-3115.73M+260.5%2026-03-30, From 2024-01-01
2023-12-314.36M+3.0%2025-03-31, From 2023-01-01
2022-12-314.24M+2.5%2024-04-01, From 2022-01-01
2021-12-314.13M+2.6%2023-03-27, From 2021-01-01
2020-12-314.03M+7.6%2022-03-31, From 2020-01-01
2019-12-313.75M+33.0%2021-04-01, From 2019-01-01
2018-12-312.82Mn/c2021-01-19, From 2018-01-01
2017-12-3115.77M+768.2%2019-03-21, From 2017-01-01
2016-12-311.82M+17.3%2018-03-23, From 2016-01-01
2015-12-311.55Mn/c2017-03-31, From 2015-01-01
2014-12-3114.90M+1.2%2016-03-30, From 2014-01-01
2013-12-3114.72M+0.9%2015-03-05, From 2013-01-01
2012-12-3114.59M+1.0%2014-03-06, From 2012-01-01
2011-12-3114.44M+0.9%2013-03-15, From 2011-01-01
2010-12-3114.31Mn/a2012-03-09, From 2010-01-01